Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 Biomarker disease BEFREE This review focuses on the clinical significance of MRSA infections and new approaches for the laboratory diagnosis and epidemiologic typing of MRSA strains. 31523762 2020
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 Biomarker disease BEFREE Currently, this organism's ability in developing resistance to antibiotics is notorious; methicillin-resistant Staphylococcus aureus-MRSA-is known for its resistance to methicillin, oxacillin, and others. 31667799 2020
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 Biomarker disease BEFREE Methicillin-sensitive and methicillin-resistant Staphylococcus aureus (MSSA and MRSA, respectively) in the nostrils of dogs and workers at an animal shelter were cultured. 30924987 2019
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 GeneticVariation disease BEFREE Using a novel model of MRSA population-based surveillance, sociodemographic risk associations, yearly geospatial dissemination and prevalence of CA-MRSA infections over an 11 year period was identified in an urban healthcare jurisdiction of Calgary. 31288765 2019
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 Biomarker disease BEFREE Delafloxacin is an oral or intravenous (IV) antibiotic indicated for the treatment of acute bacterial skin and skin structure infections (ABSSSI), including both gram-positive (including methicillin-resistant Staphylococcus aureus [MRSA]) and gram-negative organisms. 30957167 2019
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 Biomarker disease BEFREE The identification of a high percentage of MRSA and presence of VRSA and VISA isolates is a serious warning about the treatment of future MRSA infections and reveals the need for new and effective therapeutic agents. 30811005 2019
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 GeneticVariation disease BEFREE Of the Gram-positive organisms, 75 (57%) were coagulase-negative Staphylococci (CoNS), 15 (11%) Staphylococcus aureus (including one methicillin-resistant Staphylococcus aureus [MRSA]) and 8 (6%) Corynebacterium spp. 30047184 2019
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 Biomarker disease BEFREE Five (6.3%) isolates were identified as MRSA (mecA-positive). 31692060 2019
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 GeneticVariation disease BEFREE Flow cytometric (FCM) data exhibited significantly enhanced intracellular uptake propensity of terpenoids encapsulated ELE-CuONPs and accumulation of intracellular reactive oxygen species (ROS), which ensued killing of planktonic cells of extended spectrum β-lactamases (ESβL) producing Escherichia coli-336 (E. coli-336), Pseudomonas aeruginosa-621 (P. aeruginosa-621) and methicillin-resistant Staphylococcus aureus-1 (MRSA-1) clinical isolates compared to the bare surface commercial nano-CuO and bulk sized CuO. 30948112 2019
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 AlteredExpression disease BEFREE These results confirmed a synergistic effect between daptomycin plus ceftaroline and increased bactericidal activity against MRSA, suggesting that this combination may be effective for the treatment of invasive MRSA infection. 31298264 2019
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 GeneticVariation disease BEFREE Methicillin‑resistant Staphylococcus aureus (S. aureus; MRSA) is one of the most common bacterial pathogens and MRSA infections are characterized by high mortality rates. 30816474 2019
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 Biomarker disease BEFREE The antibacterial activity of the Se NPs was shown to be strongly size dependent, with 81 nm Se NPs showing the maximal growth inhibition and killing effect of methicillin-sensitive and methicillin-resistant Staphylococcus aureus (MSSA and MRSA). 31363721 2019
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 Biomarker disease BEFREE The antibiotic concentrations of drainage samples were measured by high-performance liquid chromatography, and the bioactivities of the drainage samples against methicillin-sensitive and methicillin-resistant Staphylococcus aureus (MSSA and MRSA) and E. coli were assessed. 31801510 2019
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 Biomarker disease BEFREE Implants in this study were exposed to MRSA (ATCC43300), P. aeruginosa (ATCC27853), MSSE (ATCC35984), and Candida Albicans (ATCC10231). 30409704 2019
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 Biomarker disease BEFREE These findings support the contention that the marked decline in hospital-onset MRSA infections observed in these studies is due to interventions which are specifically targeted towards MRSA. 31244994 2019
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 GeneticVariation disease BEFREE An infecting organism was identified from 70 (50%) index intraoperative cultures, with Staphylococcus aureus infections (methicillin-resistant Staphylococcus aureus [MRSA], 27; methicillin-sensitive Staphylococcus aureus, 25) being the most frequent. 30520802 2019
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 Biomarker disease BEFREE Our initial studies focused on applying this antibiotic strategy for treating African sleeping sickness (caused by Trypanosoma brucei parasites) and drug-resistant bacterial infections (in particular Methicillin-resistant Staphylococcus aureus - MRSA). 30852084 2019
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 Biomarker disease BEFREE We characterized seven OS-MRSA clinical isolates of six different <i>spa</i> types from six different states by whole-genome sequencing to identify the nucleotide sequence changes leading to the OS-MRSA phenotype. 31109981 2019
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 Biomarker disease BEFREE Over the last decade, an increasing number of infections with livestock-associated methicillin-resistant Staphylococcus aureus of clonal complex 398 (LA-MRSA CC398) in persons without contact to livestock has been registered in Denmark. 31819134 2019
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 Biomarker disease BEFREE Community-associated MRSA and livestock-associated MRSA, belonging to ST59 and ST9, respectively, were identified in both humans and pigs. 29377579 2018
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 Biomarker disease BEFREE We formulated and analyse a mathematical model to characterise the transmission co-dynamics of hospital-acquired MRSE (HA-MRSA) and community-acquired MRSE (CA-MRSA) and to investigate the long run competitiveness of the two strains in hospital. 29953912 2018
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 Biomarker disease BEFREE Methicillin-resistant Staphylococcus aureus/pseudintermedius (MRSA/MRSP), Enterobacteriaceae, and Pseudomonas species (spp.) were characterized. 30332336 2018
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 Biomarker disease BEFREE Methicillin-resistant Staphylococcus aureus CC22-MRSA-IV as an agent of dairy cow intramammary infections. 30473348 2018
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 Biomarker disease BEFREE Inhibition of autophagy can increase the ability of macrophages phagocytosed MRSA, and it is a suitable target for preventing or treating MRSA infection. 29345345 2018
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 Biomarker disease BEFREE Recently, an outbreak of skin lesions due to MRSA occurred in workers at a pig farm in regional Australia and both the humans and pigs were shown to have a high prevalence of carriage of either the human-strain ST93 or porcine strain ST398. 29718930 2018